Form 4: Cross Country Healthcare Executive Marc S. Krug Reports Stock Transactions
SEC Form 4 Filing
Marc S. Krug, Group President, Delivery at Cross Country Healthcare, reports acquisition and disposal of common stock related to vesting of restricted shares and tax obligations.
Summary
- On March 31, 2024, Marc S. Krug, Group President, Delivery at Cross Country Healthcare, engaged in transactions involving the company's common stock.
- Krug acquired 10,217 shares of common stock at $0, which are restricted shares vesting in three equal installments on March 31, 2025, March 31, 2026, and March 31, 2027.
- He also disposed of 2,338 shares at $18.72, 1,433 shares at $18.72, 975 shares at $18.72 and 1,124 shares at $18.72 to cover tax withholding obligations related to the vesting of restricted stock.
- Following these transactions, Krug directly owns 49,677 shares of Cross Country Healthcare common stock.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information. The acquisition of restricted stock is a slightly positive indicator.
Positives
- The acquisition of restricted shares indicates continued alignment of the executive's interests with the long-term performance of the company.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the alignment of management's interests with shareholders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and stock ownership adjustments.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of stock transactions (acquisition and disposal). |
| 03/31/2025 | First vesting date for restricted shares. |
| 03/31/2026 | Second vesting date for restricted shares. |
| 03/31/2027 | Final vesting date for restricted shares. |
| 04/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.